# INDIUM IN 111 OXYQUINOLINE
> **ANDA202586** · Abbreviated New Drug Application (Generic) · Sponsor: BWXT ITG · Approved 2018-07-25
## Drug
- **FDA Application Number:** ANDA202586
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** INDIUM IN 111 OXYQUINOLINE
- **Generic name:** INDIUM IN-111 OXYQUINOLINE
- **Active ingredients:** INDIUM IN-111 OXYQUINOLINE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** BWXT ITG
- **Manufacturer:** BWXT Medical Ltd.
- **First approval:** 2018-07-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202586)
---
*MORVS · CC0 1.0*